(Q51760981)

11 April 2018

title

Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation. (English)

1 reference

11 April 2018

9

Dominique Heymann

1 reference

11 April 2018

Stéphane Téletchéa

1

1 reference

11 April 2018

Verena Stresing

2

1 reference

11 April 2018

Soizic Hervouet

3

1 reference

11 April 2018

Marc Baud'huin

4

1 reference

11 April 2018

Marie-Françoise Heymann

5

1 reference

11 April 2018

Gildas Bertho

6

1 reference

11 April 2018

Céline Charrier

7

1 reference

11 April 2018

Kosei Ando

8

1 reference

11 April 2018

publication date

1 June 2014

1 reference

11 April 2018

Journal of Bone and Mineral Research

published in

1 reference

11 April 2018

volume

29

1 reference

11 April 2018

issue

6

1 reference

11 April 2018

page(s)

1466-1477

1 reference

11 April 2018

Skeletal remodeling in health and disease

cites work

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

Osteoclast differentiation and activation

21 January 2018

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools

21 January 2018

1 reference

Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.

21 January 2018

1 reference

Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration

21 January 2018

1 reference

Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma

21 January 2018

1 reference

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

21 January 2018

1 reference

Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma

21 January 2018

1 reference

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences

21 January 2018

1 reference

RANKL-RANK signaling in osteoclastogenesis and bone disease

21 January 2018

1 reference

A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss

21 January 2018

1 reference

Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo

21 January 2018

1 reference

Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

21 January 2018

1 reference

Structural and functional insights of RANKL-RANK interaction and signaling

21 January 2018

1 reference

Structure-based development of a receptor activator of nuclear factor- B ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis

21 January 2018

1 reference

Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively

21 January 2018

1 reference

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

21 January 2018

1 reference

21 January 2018

1 reference

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

21 January 2018

1 reference

Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm.

21 January 2018

1 reference

Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival

21 January 2018

1 reference

Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions

21 January 2018

1 reference

Clean STD-NMR spectrum for improved detection of ligand-protein interactions at low concentration of protein

21 January 2018

1 reference

Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis

21 January 2018

1 reference

Proteoglycans and osteolysis

21 January 2018

1 reference

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

21 January 2018

1 reference

Cooperativity of allosteric receptors

21 January 2018

1 reference

DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process

21 January 2018

1 reference

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha

21 January 2018

1 reference

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo

21 January 2018

1 reference

An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma

21 January 2018

1 reference

NMR applications for identifying β-TrCP protein-ligand interactions

21 January 2018

1 reference

Bisphosphonates: new therapeutic agents for the treatment of bone tumors

21 January 2018

1 reference

Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

21 January 2018

1 reference

Protein-peptide interactions adopt the same structural motifs as monomeric protein folds

21 January 2018

1 reference

Community-wide assessment of protein-interface modeling suggests improvements to design methodology

21 January 2018

1 reference

Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit

21 January 2018

1 reference

Hit and lead generation: beyond high-throughput screening

21 January 2018

1 reference

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations

21 January 2018

1 reference

Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations

21 January 2018

1 reference

dbSNP: the NCBI database of genetic variation

21 January 2018

1 reference

Impact of mutations on the allosteric conformational equilibrium

21 January 2018

1 reference

Modularity in the TNF-receptor family

21 January 2018

1 reference

Discovering and improving novel peptide therapeutics

21 January 2018

1 reference

Peptide-based delivery to bone.

21 January 2018

1 reference

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.2170

1 reference

11 April 2018

PubMed ID

24390798

1 reference

11 April 2018